2017 American Transplant Congress

Sunday, April 30, 2017

2:42pm-2:54pm

Personalizing Immunosuppression with Molecular Phenotyping in Pediatric Liver Transplantation.

M. Ningappa, C. Ashokkumar, Q. Sun, B. Higgs, K. Soltys, G. Bond, G. Mazariegos, R. Sindhi.

Concurrent Session: Pediatric Liver  •  E271a

2:42pm-2:54pm

Prospective Randomized Trial for Predicting CMV Infection According to Baseline CMV-Specific T-Cell Immunity in Kidney Transplant Patients.

M. Jarque,² E. Melilli,¹ A. Gutierez,³ F. Moreso,⁴ L. Guirado,⁵ A. Manonelles,¹ J. Cruzado,^1,2 S. Luque,² E. Crespo,² N. Montero,¹ F. Diekman,⁶ J. Grinyó,^1,2 O. Bestard.¹

Concurrent Session: Cutting Edge - Cytomegalovirus  •  E353C

2:54pm-3:06pm

Antidepressant Medication Use Before and After Kidney Transplant: Implications for Post-Transplant Outcomes.

K. Lentine,¹ A. Naik,² R. Ouseph,¹ Z. Zhang,¹ D. Axelrod,³ D. Segev,⁴ V. Dharnidharka,⁵ D. Brennan,⁵ H. Randall,¹ R. Gadi,¹ N. Lam,⁶ G. Hess,⁷ M. Schnitzler,^1,8 B. Kasiske.⁸

Concurrent Session: Psychosocial and Mediation Adherence Concerns  •  E271b

2:54pm-3:06pm

Association with Tacrolimus Intraindividual Variability, Acute Microinflammation Based on 1 Year-Transplanted Kidney Biopsy After Transplantation, and Biopsy-Proven Acute Rejection.

S.-Y. Kim, S.-I. Min, W. Cho, S. Cho, M.-J. Cho, S. Ahn, S.-K. Min, J. Ha.

Concurrent Session: Assessing Risk for Antibody-Mediated Rejection in Kidney Transplant Recipients  •  E354a

2:54pm-3:06pm

Blood Transfusion Induced Donor Specific Antibodies Are Associated with Rejection and Graft Failure.

S. Hassan,¹ F. Regan,^2,3 C. Brown,⁴ A. Harmer,³ N. Anderson,³ P. Brookes,⁵ D. Taube,¹ M. Willicombe.¹

Concurrent Session: Kidney HLA Antibodies  •  E354b

2:54pm-3:06pm

Dual Targeting with Carfilzomib and Tocilizumab Abrogates Antibody-Mediated Rejection and Prolongs Survival in a Highly Sensitized Rhesus Model of Kidney Transplantation.

B. Ezekian, J. Kwun, M. Manook, K. Freischlag, V. Curfman, E. Branum, J. Park, J. Yi, S. Jordan, S. Knechtle.

Concurrent Session: B Cells in Alloimmunity  •  E350

2:54pm-3:06pm

Impact of Antihypertensive (AHT) Choice and Advagraf^® Dose on Interstitial Fibrosis/Tubular Atrophy (IF/TA) and IF/TA Progression in Renal Allografts 24 Months Post-Transplantation (Tx).

S. Cockfield,¹ D. Rush,² S. Wilson,³ J. Howell,⁴ FKC-014 Study Group.

Concurrent Session: Novel Immunosuppression Regimens - Tacrolimus Combinations  •  E450b

2:54pm-3:06pm

Living and Deceased Donor Uterus Transplantation – The 2-Arm Czech Uterus Transplant Trial: The First Year Report with Four Cases Done so Far.

J. Fronek,¹ R. Chmel,² L. Janousek,¹ M. Novackova,² J. Matecha,² M. Olausson.³

Concurrent Session: VCA  •  E270

2:54pm-3:06pm

Longitudinal Study of Donor Specific Antibodies in a Pediatric Kidney Transplant Population; Response to Optimization of Anti-Proliferative Therapy.

A. Rounds, M. Moss, M. Bock, J. Goebel.

Concurrent Session: Kidney: Pediatric Immune Injury and Recurrent Disease  •  E451a

2:54pm-3:06pm

mTOR Inhibition Diminishes Peripheral Blood CD8⁺CD28^–CD38^hi Effector/Memory T Cells and Facilitates Resolution of Belatacept-Refractory Kidney Rejection.

C. Castro-Rojas,¹ A. Godarova,¹ A. Leino,² R. Alloway,² M. Jordan,³ E. Woodle,² D. Hildeman.¹

Concurrent Session: Innate Pathways of Clinical Alloreactivity  •  E352